About
OneOme

OneOme's mission

OneOme is working to deliver the highest quality, most cost-effective pharmacogenomic testing and tools for all providers across the globe to use in everyday patient care. By increasing adoption of pharmacogenomics, OneOme and the RightMed Test may help providers make more informed medication decisions, with the aim of decreasing medication trial and error and reducing healthcare costs.

People of OneOme

Leadership Toggle icon

  • Patrick McIntyre

    PATRICK MCINTYRE — CHIEF EXECUTIVE OFFICER

    Patrick joined OneOme as Chief Executive Officer in July 2019. Patrick has more than 25 years of healthcare experience, the vast majority of which has been in leadership roles over advanced analytics, healthcare economics, clinical informatics, and medical finance in national and regional payer organizations. He has built and led industry-leading analytics capabilities at UnitedHealthcare/Optum, Anthem, and Aetna. Patrick received his MBA from Winthrop University and his BBA from Texas Tech University. He is a former Certified Public Accountant in South Carolina, and he served for 5 years on active duty in the United States Marine Corps.

  • Bronwyn Hartung

    BRONWYN HARTUNG, PHD, HCLD(ABB) — LABORATORY DIRECTOR

    Bronwyn is the founder of Phoenix Laboratory Consulting, based in Prospect, Kentucky. She has 15 years of experience in molecular genetics, with expertise in the design and validation of laboratory-developed tests, high-complexity clinical laboratory operations, quality systems, regulatory compliance, and medical device software. Bronwyn is a contributing member of CPIC, PharmVar, and the FDA PGx Collaborative Community, and she is on the steering committee of the STRIPE Initiative. She earned her B.S. in Biology at Trinity University and her Ph.D. at Indiana University, followed by a postdoctoral fellowship in microbial pathology at the University of Iowa.

  • Colin Schulte

    COLIN SCHULTE — SENIOR DIRECTOR OF FINANCE

    Colin joined OneOme as a Senior Finance Director in December 2019. He is a Certified Healthcare Financial Professional (CHFP), experienced in financial reporting, budgeting, modeling, and accounting. His technical finance and accounting experience is paralleled by industry knowledge, system expertise, and collaboration skills. Previously, he held roles leading financial analytics for the University of Minnesota Physicians and managing finance and accounting at Gravie, a venture-backed health insurance brokerage. Colin received his BA from Hamline University and is currently completing his MBA at Saint Mary’s University of Minnesota.

  • Julie England, MD

    JULIE ENGLAND, MD — Interim Chief Medical Officer

    Dr. Julie England joined OneOme in September 2018. She is a board-certified physician with over 15 years of clinical experience in Family Medicine, which has allowed her to encounter a variety of medical issues. While performing in this setting, she became interested in precision medicine and eventually opened up a small concierge lifestyle precision medicine practice in 2017. Julie received her B.A. in Biology from the University of Michigan and her M.D. from the American University of the Caribbean College of Medicine. She completed her residency training in Family Medicine at the University of Minnesota.

  • Tanya Rylee

    TANYA RYLEE — Chief Administrative Officer

    Prior to joining OneOme, Tanya worked at Anthem, Inc. for almost six years in executive roles focused on strategy, planning, and process improvement. Previously, she was employed by UnitedHealth Group for 11 years, where she worked within the areas of program and project management and served as chief of staff for Quality Management and Performance. In 2016, she was honored as one of the 51 Women in Business award winners by the Minneapolis/St. Paul Business Journal. Tanya holds a B.S. in Dietetics and a minor in Psychology from the University of North Dakota and a M.B.A. degree from Webster University.

Mayo Clinic Co-Founders

  • John Black

    JOHN L. BLACK III, M.D. — MAYO CLINIC, CO-FOUNDER ONEOME

    John L. Black III, M.D. is one of the co-founders of OneOme and also a consultant in the Division of Clinical Biochemistry and Immunology with a joint appointment in the Department of Psychiatry and Psychology at Mayo Clinic in Rochester. He joined the staff of Mayo Clinic in 1985 and is currently the co-director of the Personalized Genomics Laboratory. He received his B.A. and M.S. in psychology from the University of Wyoming. He received his M.D. (cum laude) from Creighton University School of Medicine. He is board certified in general, geriatric, and addiction psychiatry and is a clinical chemist.

  • Liewei Wang

    LIEWEI WANG, M.D., Ph.D. — MAYO CLINIC, Co-founder OneOme

    Dr. Wang is a professor in the Department of Molecular Pharmacology and Experimental Therapeutics (MPET) at Mayo Clinic Rochester. Her research involves the application of high-throughput "omics" technologies to identify biomarkers that might help us individualize cancer therapies, understand mechanisms of drug action, and facilitate target identification and drug development. She is also a co-leader of the Mayo Pharmacogenomics Program within the Mayo CIM, where many of the projects involving personalized medicine have been conducted. She is the co-PI for the Mayo-NIH clinical pharmacology T32 training grant and the Associate Director for the Mayo MPET graduate program.

  • Richard Weinshilboum

    RICHARD WEINSHILBOUM, M.D. — MAYO CLINIC, Co-founder OneOme

    Dr. Weinshilboum received B.A. and M.D. degrees from the University of Kansas, followed by residency training in internal medicine at the Massachusetts General Hospital. He was also a pharmacology Research Associate at the National Institutes of Health (NIH). He began his affiliation with the Mayo Medical School and Mayo Clinic in 1972, where he is presently Professor of Pharmacology and Medicine and Mary Lou and John H. Dasburg Professor of Cancer Genomics Research. He currently directs the Pharmacogenomics Program of the Mayo Center for Individualized Medicine and is co-Principal Investigator of the long-standing US NIH Pharmacogenomics Research Network Center at the Mayo Clinic.

Team Toggle icon

Alice Kirchhoff

Marketing

Alice
Kirchhoff

Annika Sand

Commercial Operations

Annika
Sand

Ben Metzger

Software Development

Ben
Metzger

Bernard Esquivel, MD, MHA, PhD

Medical Affairs

Bernard
Esquivel, MD, MHA, PhD

Catie Pfeilsticker

Laboratory Operations

Catie
Pfeilsticker

Chiara Aziz

Laboratory Operations

Chiara
Aziz

Colin Pistulka

Commercial Operations

Colin
Pistulka

Colleen Owen

Human Resources

Colleen
Owen

Davor Babic

Business Development

Davor
Babic

Ghada Elnashar, PharmD, MS

Medical Affairs

Ghada
Elnashar, PharmD, MS

Hunter Kievet

Software Development

Hunter
Kievet

Jacob Sevlie

Software Development

Jacob
Sevlie

Jordan Gutzman

Sales

Jordan
Gutzman

Julie Hessick, RPh

Business Development

Julie
Hessick, RPh

Kathleen Bosse, PharmD

Clinical Development

Kathleen
Bosse, PharmD

Kirsten Bauer

Laboratory Operations

Kirsten
Bauer

Kurt Wiersma

Software Development

Kurt
Wiersma

Lilly Drew

Commercial Operations

Lilly
Drew

Lori Borchers

Business Development

Lori
Borchers

Lydia Kantor

Marketing

Lydia
Kantor

Megan Adelman, PharmD

Clinical Development

Megan
Adelman, PharmD

Morgan Donaldson

Business Development

Morgan
Donaldson

Rissa Hall

Commercial Operations

Rissa
Hall

Sue Irby

Product Management

Sue
Irby

Tyler Koep, PhD

Medical Affairs

Tyler
Koep, PhD

Vaishnavi Soundararajan, PharmD (Intl.), MS

Clinical Development

Vaishnavi
Soundararajan, PharmD (Intl.), MS

Victor Tam, PharmD

Medical Affairs

Victor
Tam, PharmD

Wrenda Teeple, PharmD

Clinical Development

Wrenda
Teeple, PharmD

Select partners

alliance healthcare logo
family care path logo
tucker logo
medcan logo
doseme logo
personamed logo
rainbow logo
chemowave logo
St. Catherine logo
Apollo Clinical Pharmacy Logo

Awards

fast company logo

Named one of the World's 50 Most Innovative Companies for 2018 by Fast Company.

#22 overall | #2 in biotech

Icon
Icon
Icon

  • The RightMed Test must be ordered by a physician.
  • The RightMed Test, as with all genomic testing, has limitations. Always discuss the test with a healthcare provider knowledgeable about the test and to see if it's right for you.
  • RightMed Test results are not a substitute for medical advice and should only be used in consultation with a medical professional.
  • The RightMed Test does not determine the best medication for the patient; it is a tool to provide additional information to the patient’s healthcare provider. The healthcare provider should take other factors into consideration regardless of genotype.
  • Independent healthcare providers available through OneOme's service will not have all of your health history, which may cause the test results to be subject to a different interpretation than by your personal physician.
  • DO NOT MAKE ANY CHANGES TO YOUR CURRENT MEDICATIONS OR DOSING WITHOUT CONSULTING YOUR HEALTHCARE PROVIDER.